Daniel Cressy yawned, tired after three days of watching a machine pull blood out of his body, extract his stem cells and ...

Connecticut is now participating in a new federal program aimed at expanding treatment access for patients with sickle cell ...

Sickle cell anemia is one of a group of inherited disorders known as sickle cell disease. It affects the shape of red blood cells, which carry oxygen to all parts of the body. Red blood cells are ...

Fulcrum Therapeutics reports promising late-stage data for sickle cell drug pociredir, with notable hemoglobin improvements.

According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from ...

After decades of excruciating pain, a breakthrough sickle cell disease treatment made all the difference for one patient.

States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Ahmedabad (Gujarat) [India], August 7: Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's leading ...

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex ...

Vertex Pharmaceuticals beat Wall Street estimates for quarterly results on Monday, helped by demand for its new cystic ...

Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...